BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1009601)

  • 21. [Anticytogram (author's transl)].
    Ciuffi M
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():662-72. PubMed ID: 400252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical situation and therapy of ovarian carcinoma at Gynaecological Hospital of Jena University, between 1967 and 1976 (author's transl)].
    Meinhold P; Sommer H; Nöschel H; Günther M
    Zentralbl Gynakol; 1981; 103(21):1280-8. PubMed ID: 7324630
    [No Abstract]   [Full Text] [Related]  

  • 23. [The significance of the so-called "second look-operation" following the cytostatic treatment (author's transl)].
    Balák K
    Cesk Gynekol; 1976 Dec; 41(10):724-5. PubMed ID: 1009604
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies into dependence of sensitivity of cytostatics on overlap index of ovarian cancer in cell cultures (author's transl)].
    Schindler C
    Zentralbl Gynakol; 1982; 104(3):156-9. PubMed ID: 7043954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Old drugs revisited, new drugs, and experimental approaches in ovarian cancer therapy.
    McGuire WP; Rowinsky EK
    Semin Oncol; 1991 Jun; 18(3):255-69. PubMed ID: 2042065
    [No Abstract]   [Full Text] [Related]  

  • 27. Second-line chemotherapy for ovarian cancer.
    Weiss GR
    Clin Obstet Gynecol; 1986 Sep; 29(3):665-77. PubMed ID: 3757343
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of 2 combined chemotherapy protocols in the treatment of stage III-IV ovarian cancer patients].
    Marenich AF; Perevodchikova NI; Grigorova TM; Pashkiavichus RI
    Vestn Akad Med Nauk SSSR; 1980; (5):28-32. PubMed ID: 7395336
    [No Abstract]   [Full Text] [Related]  

  • 29. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemosensitivity testing of topotecan as second-line agent in chemotherapy of ovarian cancer].
    Qian XL; Peng ZL; Liu SL
    Ai Zheng; 2003 Dec; 22(12):1352-4. PubMed ID: 14693068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence-based chemotherapy administration in advanced ovarian cancer: an impressive past, a disquieting present and an uncertain future.
    Markman M
    Gynecol Oncol; 2008 Apr; 109(1):4-7. PubMed ID: 18234303
    [No Abstract]   [Full Text] [Related]  

  • 33. Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?
    Larsen E; Blaakaer J
    Acta Obstet Gynecol Scand; 2009; 88(4):373-7. PubMed ID: 19253061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of advanced ovarian carcinoma.
    N Engl J Med; 1979 Mar; 300(12):676-7. PubMed ID: 763291
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comprehensive therapy of ovarian neoplasms. II. Directed chemotherapy of ovarian neoplasms].
    Dvorák O; Andrýsek O; Stránská E
    Zentralbl Gynakol; 1972 Mar; 94(10):326-9. PubMed ID: 5030724
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy for ovarian cancer.
    Boronow RC; Bell WN
    J Miss State Med Assoc; 1968 Nov; 9(11):515-9. PubMed ID: 5722884
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chemoresistance in ovarian cancer. State of the art and future prospects].
    Katsaros D; Fracchioli S; Arese P; Enria R; Cassinelli P; Mingrone K; Piccinno R; Rigault de la Longrais IA; Massobrio M
    Minerva Ginecol; 1999 Dec; 51(12):483-99. PubMed ID: 10767997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress in the chemotherapy of ovarian cancer].
    Honetz N
    Wien Med Wochenschr; 1982 Jul; 132(13-14):319-24. PubMed ID: 6291259
    [No Abstract]   [Full Text] [Related]  

  • 39. The changing role of surgery and chemotherapy in the management of ovarian cancer.
    Ehrlich CE
    Ala J Med Sci; 1986 Jan; 23(1):24-7. PubMed ID: 3754094
    [No Abstract]   [Full Text] [Related]  

  • 40. [Simultaneous radio-chemotherapy of advanced epithelial ovarian cancer--results after three years (author's transl)].
    Szepesi T; Kärcher KH; Seitz W; Kogelnik HD; Reinartz G; Janisch H; Szalay S
    Wien Klin Wochenschr; 1981 Apr; 93(8):256-61. PubMed ID: 6167078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.